Cargando…
Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors
Glioblastoma multiforme (GBM) remains refractory to conventional therapy. CD133+ GBM cells have been recently isolated and characterized as chemo-/radio-resistant tumor-initiating cells and are hypothesized to be responsible for post-treatment recurrence. In order to explore the molecular properties...
Autores principales: | Liu, Qinghai, Nguyen, David H., Dong, Qinghua, Shitaku, Peter, Chung, Kenneth, Liu, On Ying, Tso, Jonathan L., Liu, Jason Y., Konkankit, Veerauo, Cloughesy, Timothy F., Mischel, Paul S., Lane, Timothy F., Liau, Linda M., Nelson, Stanley F., Tso, Cho-Lea |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705704/ https://www.ncbi.nlm.nih.gov/pubmed/19468690 http://dx.doi.org/10.1007/s11060-009-9919-z |
Ejemplares similares
-
Protective Properties of Radio-Chemoresistant Glioblastoma Stem Cell Clones Are Associated with Metabolic Adaptation to Reduced Glucose Dependence
por: Ye, Fei, et al.
Publicado: (2013) -
Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients
por: Yong, William H., et al.
Publicado: (2015) -
Essential Gene Pathways for Glioblastoma Stem Cells: Clinical Implications for Prevention of Tumor Recurrence
por: Yamada, Kazunari, et al.
Publicado: (2011) -
Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age
por: Lee, Yohan, et al.
Publicado: (2008) -
Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide
por: Tso, Jonathan L., et al.
Publicado: (2015)